Charles Rosier: Life Story
It was in 1996, at Lehman Brothers, when Charles rosier started his profession before becoming the head of finance at Goldman Sachs Bank, shortly after joining UBS Warburg Investment Bank. Charles Rosier took two years of additional classes at a private school called Integrale, where he studied for ESCP Europe. He is interested in many things like studies, extreme sports, handling environmentally-friendly activities and culture.
Charles Rosier’s appointment at Lehman Brothers in 1996 was his first step towards his future. Later, he transferred to UBS Warburg to be the manager for their Debt Capital Market Division in 1997. In August 2010, he became a member of BTG Pactual. He became a partner at BTG Pactual, an investment bank located in Latin America. Charles Rosier was offered a job at Goldman Sachs in the year 1999. When he accepted the offer, he became their Managing Director.
How Charles Rosier Was Educated
Charles Rosier successfully was awarded his first scientific Baccalaureate degree (equal to A-levels in the UK). In order for him to accomplish more French qualifications, he took two years of additional classes in preparation. Whilst pursuing his job, he occupied several different positions, which transformed him into seasoned banker. Charles Rosier was able to establish his career after getting a degree at ESCP Europe.
Projects related to Upholding Culture
Charles Rosier has always loved culture and music. This shows in the way he supports movies and singers. Showing his great appreciation for culture and music, he supported a notable French female artist. He was able to help a French performer with her debut album in 2012 and did wonderful things for a Silver Lion-winning film in 2006. In the year 2006, Charles Rosier supported a film made by a well-known Italian screenwriter and director, which went on to win a Silver Lion award at the well-known Venice film festival.
Charles Rosier and His Healthcare Advocacies
He is also one of the investors of Mapreg, a laboratory in Paris that examines depression, strokes and other serious conditions. The investment by Charles Rosier allowed them to do research and, because of that, he was given a specific profit-share. Baulieu and his co-workers found it challenging to develop a new drug due to lack of budget, which he rectified. Mapreg is a pharmaceutical company headed by Professor Etienne Baulieu. They were funded by Charles Rosier when he started to conduct healthcare projects.